Plectin, encoded by PLEC, is a cytoskeletal and scaffold protein with a number of unique isoforms that act on various cellular functions such as cell adhesion, signal transduction, cancer cell invasion, and migration. While plectin has been shown to display high expression and mislocalization in tumor cells, our knowledge of the biological significance of plectin and its isoforms in tumorigenesis remain limited. In this study, we first performed pathway enrichment analysis to identify cancer hallmark proteins associated with plectin. Then, a pan-cancer analysis was performed using RNA-seq data collected from the Cancer Genome Atlas (TCGA) to detect the mRNA expression levels of PLEC and its transcript isoforms, and the prognostic as well as diagnostic significance of the transcript isoforms was evaluated considering cancer stages. We show here that several tissue specific PLEC isoforms are dysregulated in different cancer types and stages but not the expression of PLEC. Among them, PLEC 1d and PLEC 1f are potential biomarker candidates and call for further translational and personalized medicine research. This study makes a contribution as a stride to unravel the molecular mechanisms underpinning plectin isoforms in cancer development and progression by revealing the potent plectin isoforms in different stages of cancer as potential early cancer detection biomarkers. Importantly, uncovering how plectin isoforms guide malignancy and particular cancer types by comprehensive functional studies might open new avenues toward novel cancer therapeutics.
Get full access to this article
View all access options for this article.
References
1.
AndräK, LassmannH, BittnerR, et al.Targeted inactivation of plectin reveals essential function in maintaining the integrity of skin, muscle, and heart cytoarchitecture. Genes Dev, 1997; 11:3143–3156; doi: 10.1101/gad.11.23.3143
2.
AndräK, KornackerI, JorglA, et al.Plectin isoform specific rescue of the hemidesmosomal defects in plectin (−/−) keratinocytes. J Invest Dermatol, 2003; 120:189–197; doi: 10.1046/j.1523-1747.2003.12027.x
3.
BauschD, Mino-KenudsonM, CastilloCF-D, et al.Plectin-1 is a biomarker of malignant pancreatic intraductal papillary mucinous neoplasms. J Gastrointest Surg, 2009; 13(11):1948–1954; doi: 10.1007/s11605-009-1001-9
4.
BauschD, ThomasS, Mino-KenudsonM, et al.Plectin-1 as a novel biomarker for pancreatic cancer. Clin Cancer Res, 2011; 17(2):302–309; doi: 10.1158/1078-0432.CCR-10-0999
5.
BoczonadiV, McInroyL, MäättäA. Cytolinker cross-talk: Periplakin N-terminus interacts with plectin to regulate keratin organisation and epithelial migration. Exp Cell Res, 2007; 313(16):3579–3591; doi: 10.1016/j.yexcr.2007.07.005
6.
BuckupM, RiceMA, HsuE-C, et al.Plectin is a regulator of prostate cancer growth and metastasis. Oncogene, 2021; 40(3):663–676; doi: 10.1038/s41388-020-01557-9
7.
BurchTC, WatsonMT, NyalwidheJO. Variable metastatic potentials correlate with differential plectin and vimentin expression in syngeneic androgen independent prostate cancer cells. PLoS One, 2013; 8(5):e65005; doi: 10.1371/journal.pone.0065005
8.
CaoF, ZhouY, LiuX. Podosome formation promotes plasma membrane invagination and integrin-β3 endocytosis on a viscous RGD membrane. Commun Biol, 2020; 3(1):117; doi: 10.1038/s42003-020-0843-2
9.
CastañónMJ, WalkoG, WinterL. Plectin–intermediate filament partnership in skin, skeletal muscle, and peripheral nerve. Histochem Cell Biol, 2013; 140(1):33–53; doi: 10.1007/s00418-013-1102-0
CeramiE, GaoJ, DogrusozU, et al.The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov, 2012; 2(5):401–404; doi: 10.1158/2159-8290.CD-12-0095
12.
ChengF, KovácsIA, BarabásiAL. Network-based prediction of drug combinations. Nat Commun, 2019; 10(1):1197; doi: 10.1038/s41467-019-09186-x
13.
Chiung-ChiC, Yen-Chang,CL, Yih-ShyongL, et al.Transient knockdown-mediated deficiency in plectin alters hepatocellular motility in association with activated FAK and Rac1-GTPase. Cancer Cell Int, 2015; 15:29; doi: 10.1186/s12935-015-0177-1
14.
DasaSSK, DiakovaG, SuzukiR, et al.Plectin-targeted liposomes enhance the therapeutic efficacy of a PARP inhibitor in the treatment of ovarian cancer. Theranostics, 2018; 8(10):2782–2798; doi: 10.7150/thno.23050
15.
DeevRV, BardakovSN, MavlikeevMO, et al.Glu20Ter variant in PLEC 1f isoform causes limb-girdle muscle dystrophy with lung injury. Front Neurol, 2017; 8:367; doi: 10.3389/fneur.2017.00367
16.
DumasV, KanitakisJ, CharvatS, et al.Expression of basement membrane antigens and matrix metalloproteinases 2 and 9 in cutaneous basal and squamous cell carcinomas. Anticancer Res, 2000; 19(4B):2929–2938.
FuchsP, ZörerM, ReipertS, et al.Targeted inactivation of a developmentally regulated neural plectin isoform (Plectin 1c) in mice leads to reduced motor nerve conduction velocity. J Biol Chem, 2009; 284(39):26502–26509; doi: 10.1074/jbc.M109.018150
20.
GaoJ, AksoyBA, DogrusozU, et al.Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal, 2013; 6(269):pl1; doi: 10.1126/scisignal.2004088
21.
GostyńskaKB, NijenhuisM, LemminkH, et al.Mutation in exon 1a of PLEC, leading to disruption of plectin isoform 1a, causes autosomal-recessive skin-only epidermolysis bullosa simplex. Hum Mol Genet, 2015; 24(11):3155–3162; doi: 10.1093/hmg/ddv066
22.
GundesliH, TalimB, KorkusuzP, et al.Mutation in exon 1f of PLEC, leading to disruption of plectin isoform 1f, causes autosomal recessive limb-girdle muscular dystrophy. A J Hum Genet, 2010; 87(6):834–841; doi: 10.1016/j.ajhg.2010.10.017
23.
HanahanD. Hallmarks of cancer: New dimensions. Cancer Discov, 2022; 12(1):31–46; doi: 10.1158/2159-8290.CD-21-1059
24.
HoshinoD, BranchKM, WeaverAM. Signaling inputs to invadopodia and podosomes. J Cell Sci, 2013; 126 (Pt14):2979–2989; doi: 10.1242/jcs.079475
25.
HuberW, CareyVJ, GentlemanR, et al.Orchestrating high-throughput genomic analysis with Bioconductor. Nat Methods, 2015; 12(2):115–121; doi: 10.1038/nmeth.3252
KatadaK, TomonagaT, SatohM, et al.Plectin promotes migration and invasion of cancer cells and is a novel prognostic marker for head and neck squamous cell carcinoma. J Proteomics, 2012; 75(6):1803–1815; doi: 10.1016/j.jprot.2011.12.018
28.
KellyKA, BardeesyN, AnbazhaganR, et al.Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma. PLoS Med, 2008; 5(4):e85; doi: 10.1371/journal.pmed.0050085
29.
KoniecznyP, FuchsP, ReipertS, et al.Myofiber integrity depends on desmin network targeting to Z-disks and costameres via distinct plectin isoforms. J Cell Biol, 2008; 181(4):667–681; doi: 10.1083/jcb.200711058
30.
KrausovaA, BuresovaP, SarnovaL, et al.Plectin ensures intestinal epithelial integrity and protects colon against colitis. Mucosal Immunol, 2021; 14(3):691–702; doi: 10.1038/s41385-021-00380-z
31.
LiuY, WangJ, WuS, et al.A model for isoform-level differential expression analysis using RNA-seq data without pre-specifying isoform structure. PLoS One, 2022; 17(5):e0266162; doi: 10.1371/journal.pone.0266162
32.
LoveMI, HuberW, AndersS. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol, 2014; 15(2):550; doi: 10.1186/s13059-014-0550-8
33.
MandrekarJN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol, 2010; 5(9):1315–1316; doi: 10.1097/JTO.0b013e3181ec173d
34.
MatsubaraT, UrataM, AddisonWN, et al.Expression analysis of plectin isoforms in osteoclast. Dent Oral Craniofac Res, 2019; 5:1–3; doi: 10.15761/DOCR.1000286
35.
McInroyL, MäättäA. Plectin regulates invasiveness of SW480 colon carcinoma cells and is targeted to podosome-like adhesions in an isoform-specific manner. Exp Cell Res, 2011; 317(17):2468–2478; doi: 10.1016/j.yexcr.2011.07.013
36.
MroczekM, DurmusH, TöpfA, et al.Four individuals with a homozygous mutation in Exon 1f of the PLEC gene and associated myasthenic features. Genes (Basel), 2020; 11(7):716; doi: 10.3390/genes11070716
37.
Nagy Á, MunkácsyG, GyőrffyB. Pancancer survival analysis of cancer hallmark genes. Sci Rep, 2021; 11:6047; doi: 10.1038/s41598-021-84787-5
38.
Osmanagic-MyersS, GregorM, WalkoG, et al.Plectin-controlled keratin cytoarchitecture affects MAP kinases involved in cellular stress response and migration. J Cell Biol, 2006; 174(4):557–568; doi: 10.1083/jcb.200605172
39.
Osmanagic-MyersS, WicheG. Plectin-RACK1 (receptor for activated C kinase 1) scaffolding: A novel mechanism to regulate protein kinase C activity. J Biol Chem, 2004; 279(18):18701–18710; doi: 10.1074/jbc.M312382200
40.
PanQ, ShaiO, LeeLJ, et al.Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet, 2008; 40(12):1413–1415; doi:10.1038/ng.259
41.
PanL, DinhHQ, PawitanY, et al.Isoform-level quantification for single-cell RNA sequencing. Bioinformatics, 2022; 38(5):1287–1294; doi: 10.1093/bioinformatics/btab807
42.
PawarH, KashyapMK, SahasrabuddheNA, et al.Quantitative tissue proteomics of esophageal squamous cell carcinoma for novel biomarker discovery. Cancer Biol Ther, 2011; 12(6):510–522; doi: 10.4161/cbt.12.6.16833
43.
PerezSM, BrintonLT, KellyKA. Plectin in cancer: From biomarker to therapeutic target. Cells, 2021; 10(9):2246; doi: 10.3390/cells10092246
44.
PrechovaM, AdamovaZ, SchweizerAL, et al.Plectin-mediated cytoskeletal crosstalk controls cell tension and cohesion in epithelial sheets. J Cell Biol, 2022; 221(3):e202105146; doi: 10.1083/jcb.202105146
45.
PuiffeML, Le PageC, Filali-MouhimA, et al.Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer. Neoplasia, 2007; 9(10):820–829; doi: 10.1593/neo.07472
46.
RayTA, CochranK, KozlowskiC, et al.Comprehensive identification of mRNA isoforms reveals the diversity of neural cell-surface molecules with roles in retinal development and disease. Nat Commun, 2020; 11(1):3328; doi: 10.1038/s41467-020-17009-7
47.
RaymondAC, GaoB, GirardL, et al.Unbiased peptoid combinatorial cell screen identifies plectin protein as a potential biomarker for lung cancer stem cells. Sci Rep, 2019; 9(1):14954; doi: 10.1038/s41598-019-51004-3
48.
ReynoldsF, PanneerN, TutinoCM, et al.A functional proteomic method for biomarker discovery. PLoS One, 2011; 6(7):e22471; doi: 10.1371/journal.pone.0022471
49.
RezniczekGA, KoniecznyP, NikolicB, et al.Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with β-dystroglycan. J Cell Biol, 2007; 176(7):965–977; doi: 10.1083/jcb.200604179
50.
ShannonP, MarkielA, OzierO, et al.Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res, 2003; 13(11):2498–2504; doi: 10.1101/gr.1239303
51.
ShinSJ, SmithJA, RezniczekGA, et al.Unexpected gain of function for the scaffolding protein plectin due to mislocalization in pancreatic cancer. Proc Natl Acad Sci USA, 2013; 110(48):19414–19419; doi: 10.1073/pnas.1309720110
52.
StaszewskaI, FischerI, WicheG. Plectin isoform 1-dependent nuclear docking of desmin networks affects myonuclear architecture and expression of mechanotransducers. Hum Mol Genet, 2015; 24(25):7373–7389; doi: 10.1093/hmg/ddv438
53.
TakkunenM, HukkanenM, LiljeströmM, et al.Podosome-like structures of non-invasive carcinoma cells are replaced in epithelial-mesenchymal transition by actin comet-embedded invadopodia. J Cell Mol Med, 2010; 14(6B):1569–1593; doi: 10.1111/j.1582-4934.2009.00868.x
54.
TateJG, BamfordS, JubbHC, et al.COSMIC: The catalogue of somatic mutations in cancer. Nucleic Acids Res, 2019; 47(D1):D941–D947; doi: 10.1093/nar/gky1015
55.
TomczakK, CzerwińskaP, WiznerowiczM. The Cancer Genome Atlas (TCGA): An immeasurable source of knowledge. Contemp Oncol (Pozn), 2015; 19(1A):A68–A77; doi: 10.5114/wo.2014.47136
56.
WalkoG, VukasinovicN, GrossK, et al.Targeted proteolysis of plectin isoform 1a accounts for hemidesmosome dysfunction in mice mimicking the dominant skin blistering disease EBS-Ogna. PLoS Genet, 2011; 7(12):e1002396; doi: 10.1371/journal.pgen.1002396
57.
WangET, SandbergR, LuoS, et al.Alternative isoform regulation in human tissue transcriptomes. Nature, 2008; 456(7221):470–476; doi: 10.1038/nature07509
XuR, HeS, MaD, et al.Plectin downregulation inhibits migration and suppresses epithelial mesenchymal transformation of hepatocellular carcinoma cells via ERK1/2 signaling. Int J Mol Sci, 2023; 24(1):73; doi.org/10.3390/ijms24010073
60.
YoneyamaMS, HatakeyamaS, HabuchiT, et al.Vimentin intermediate filament and plectin provide a scaffold for invadopodia, facilitating cancer cell invasion and extravasation for metastasis. Eur J Cell Biol, 2014; 93(4):157–169; doi: 10.1016/j.ejcb.2014.03.002
61.
ZhangD, HuoD, XieH, et al.CHG: A systematically integrated database of cancer hallmark genes. Front Genet, 2020; 11:29; doi: 10.3389/fgene.2020.00029
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
